Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

1.

Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study).

Chisholm JC, Merks JHM, Casanova M, Bisogno G, Orbach D, Gentet JC, Thomassin-Defachelles AS, Chastagner P, Lowis S, Ronghe M, McHugh K, van Rijn RR, Hilton M, Bachir J, Fürst-Recktenwald S, Geoerger B, Oberlin O; European paediatric Soft tissue sarcoma Study Group (EpSSG) and the European Innovative Therapies for Children with Cancer (ITCC) Consortium.

Eur J Cancer. 2017 Jul 21;83:177-184. doi: 10.1016/j.ejca.2017.06.015. [Epub ahead of print]

PMID:
28738258
2.

New Insights into Sinusoidal Obstruction Syndrome.

Piccin A, Sartori MT, Bisogno G, Van Schilfgaarde M, Saggiorato G, Di Pierro AM, Corvetta D, Marcheselli L, Andrea M, Gastl G, Cesaro S.

Intern Med J. 2017 Jul 14. doi: 10.1111/imj.13550. [Epub ahead of print]

PMID:
28707749
3.

Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over Italy.

Silva M, Chisari M, Signoroni S, Bassani A, Tagliabue L, Ricci A, Daversa M, Achini M, Spreafico F, Murelli M, Milano GM, Bisogno G, Coccoli L, Conte M, Garaventa A, Indolfi P, Perrotta S, Spinelli M, Mercolini F, Soloni P, Pierobon M, Di Cataldo A, Perillo T, Mascarin M, Coassin E, Veneroni L, Casanova M, Massimino M, Ferrari A.

Tumori. 2017 Jul 31;103(4):e25-e29. doi: 10.5301/tj.5000655.

4.

Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group.

D'Angelo P, Di Cataldo A, Terenziani M, Bisogno G, Collini P, Di Martino M, Melchionda F, Mosa C, Nantron M, Perotti D, Puccio G, Serra A, Catania S, Spreafico F; AIEOP Wilms Tumor Working Group.

Pediatr Blood Cancer. 2017 Jun 9. doi: 10.1002/pbc.26644. [Epub ahead of print]

PMID:
28598537
5.

Imatinib mesylate in desmoplastic small round cell tumors.

De Sanctis R, Bertuzzi A, Bisogno G, Carli M, Ferrari A, Comandone A, Santoro A.

Future Oncol. 2017 Jun;13(14):1233-1237. doi: 10.2217/fon-2016-0305. Epub 2017 Jun 7.

PMID:
28589771
6.

Attachment orientations and psychological adjustment of parents of children with cancer: A matched-group comparison.

Cusinato M, Calvo V, Bisogno G, Viscardi E, Pillon M, Opocher E, Basso G, Montanaro M.

J Psychosoc Oncol. 2017 Jun 1:1-15. doi: 10.1080/07347332.2017.1335365. [Epub ahead of print]

PMID:
28569621
7.

Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience.

Indini A, Bisogno G, Cecchetto G, Vitellaro M, Signoroni S, Massimino M, Riccipetitoni G, Zecca M, Dall'Igna P, Debora De Pasquale M, Inserra A, Chiaravalli S, Basso E, Virgone C, Sorbara S, Di Bartolomeo M, D'Angelo P, Ferrari A.

Pediatr Blood Cancer. 2017 May 31. doi: 10.1002/pbc.26658. [Epub ahead of print]

PMID:
28561949
8.

Alveolar Rhabdomyosarcoma Decellularization.

Pozzobon M, Saggioro M, D'Agostino S, Bisogno G, Muraca M, Gamba P.

Methods Mol Biol. 2017 May 25. doi: 10.1007/7651_2017_45. [Epub ahead of print]

PMID:
28540560
9.

Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.

Terenziani M, Bisogno G, Boldrini R, Cecchetto G, Conte M, Boschetti L, De Pasquale MD, Biasoni D, Inserra A, Siracusa F, Basso ME, De Leonardis F, Di Pinto D, Barretta F, Spreafico F, D'Angelo P.

Pediatr Blood Cancer. 2017 Apr 27. doi: 10.1002/pbc.26568. [Epub ahead of print]

PMID:
28449306
10.

Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.

Ferrari A, Chi YY, De Salvo GL, Orbach D, Brennan B, Randall RL, McCarville MB, Black JO, Alaggio R, Hawkins DS, Bisogno G, Spunt SL.

Eur J Cancer. 2017 Jun;78:1-6. doi: 10.1016/j.ejca.2017.03.003. Epub 2017 Apr 7.

PMID:
28391003
11.

NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.

Tombolan L, Poli E, Martini P, Zin A, Romualdi C, Bisogno G, Lanfranchi G.

Oncotarget. 2017 May 16;8(20):33086-33099. doi: 10.18632/oncotarget.16526.

12.

Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites.

Ferrari A, Magni C, Bergamaschi L, Cecchetto G, Alaggio R, Milano GM, Bertolini P, Basso E, Manzitti C, Di Martino M, Giurici N, Melchionda F, Cecinati V, Chiaravalli S, Affinita MC, Scagnellato A, Casanova M, Bisogno G.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26490. Epub 2017 Feb 24.

PMID:
28233470
13.

Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.

Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D'Ambrosio L, Willegger M, Scoccianti G, Ferrari S.

Eur J Cancer. 2017 Mar;74:9-16. doi: 10.1016/j.ejca.2016.12.016. Epub 2017 Feb 3.

PMID:
28167373
14.

Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: A report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).

Cecchetto G, Ganarin A, Bien E, Vorwerk P, Bisogno G, Godzinski J, Dall'Igna P, Reguerre Y, Schneider D, Brugières L, Leblond P, Ferrari A, Brecht I, De Paoli A, Orbach D.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26368. Epub 2016 Dec 13.

PMID:
27957799
15.

Radiologic Response Assessment in Pediatric Soft Tissue Sarcoma: Computed-Assisted Volume Evaluation.

Orsatti G, Beltrame V, Crimì F, Frigo AC, Bisogno G, Stramare R.

J Pediatr. 2017 Mar;182:327-334.e2. doi: 10.1016/j.jpeds.2016.11.040. Epub 2016 Dec 8.

PMID:
27939125
16.

Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.

Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G; RARECAREnet Working Group.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26348. Epub 2016 Nov 24.

PMID:
27882658
17.

Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.

Tombolan L, Poli E, Martini P, Zin A, Millino C, Pacchioni B, Celegato B, Bisogno G, Romualdi C, Rosolen A, Lanfranchi G.

BMC Cancer. 2016 Nov 14;16(1):886.

18.

[The contribution of the Italian Association of paediatric haematology and oncology (AIEOP)].

Rondelli R, Jankovic M, Soresina A, Valsecchi MG, De Rosa M, Cuttini M, Haupt R, Aricò M, Bisogno G, Locatelli F, Magnani C, Merletti F, Zecca M, Pession A.

Epidemiol Prev. 2016 Sep-Oct;40(5Suppl2):23-27. Italian.

19.

Papillary Thyroid Carcinoma in Pediatric Age: An Example of a Rare Tumour Managed Within a Cooperative Comprehensive Project.

Sironi G, Ferrari A, Podda M, Chiaravalli S, Bisogno G, Cecchetto G, Massimino M.

Curr Pediatr Rev. 2016;12(4):265-271. doi: 10.2174/1573396312666161031163319.

PMID:
27804856
20.

Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial.

Krischke M, Hempel G, Völler S, André N, D'Incalci M, Bisogno G, Köpcke W, Borowski M, Herold R, Boddy AV, Boos J.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1175-1184. Epub 2016 Oct 21.

Supplemental Content

Loading ...
Support Center